Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

KNSAKNSA
Showing 8 of 9 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in KINIKSA PHARMACEUTICALS INTL

GEODE CAPITAL MANAGEMENT, LLC holds 604,180 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $38.6M as of 2026-Q2. The position was increased (+1263.2% shares). KNSA represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$38.6M

Current Shares

604,180

Total Value Change

+$26.6M

Total Shares Change

+121,204

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
604,180
+1263.2%
$38.6M0.0%$63.95
47
2026-Q1
Decreased
44,320
-3.2%
$2.1M0.0%$45.37
0
2025-Q4
Increased
45,783
+0.5%
$1.9M0.0%$40.99
26
2025-Q3
Decreased
45,562
-10.6%
$1.8M0.0%$38.77
0
2025-Q2
Decreased
50,942
-89.9%
$1.4M0.0%$28.04
0
2025-Q1
Increased
505,451
+2.6%
$11.2M0.0%$23.09
29
2024-Q4
Increased
492,630
+2.0%
$9.7M0.0%$19.60
28
2024-Q3
Decreased
482,976
-43.1%
$12.1M0.0%$25.00
0

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used